PharmaCyte Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.

About PMCB

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. 

CEO
Joshua Nathaniel Silverman
CEOJoshua Nathaniel Silverman
Employees
2
Employees2
Headquarters
Las Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded
1996
Founded1996
Employees
2
Employees2

PMCB Key Statistics

Market cap
7.28M
Market cap7.28M
Price-Earnings ratio
1.39
Price-Earnings ratio1.39
Dividend yield
Dividend yield
Average volume
9.48K
Average volume9.48K
High today
$1.06
High today$1.06
Low today
$1.02
Low today$1.02
Open price
$1.06
Open price$1.06
Volume
5.00K
Volume5.00K
52 Week high
$2.42
52 Week high$2.42
52 Week low
$1.00
52 Week low$1.00

People also own

Based on the portfolios of people who own PMCB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.